5/22/2024

Alfuzosin Extended-Release Tablets

Reason for the Shortage

- Exelan has alfuzosin extended-release tablets available. Exelan is launching 1,000 count bottles in June 2024.
- Concordia has Uroxatral tablets available.
- Rising has alfuzosin extended-release tablets available.
- Unichem has alfuzosin extended-release tablets available.

Available Products

- Uroxatral oral extended release tablet, Concordia, 10 mg, bottle, 100 count, NDC 59212-0200-10
- Alfuzosin hydrochloride oral extended release tablet, Exelan Pharmaceuticals, 10 mg, bottle, 120 count, NDC 76282-0302-01
- Alfuzosin hydrochloride oral extended release tablet, Rising Pharmaceuticals, 10 mg, bottle, 90 count, NDC 57237-0114-90
- Alfuzosin hydrochloride oral extended release tablet, Unichem Pharmaceuticals, 10 mg, bottle, 90 count, NDC 29300-0155-19
- Alfuzosin hydrochloride oral extended release tablet, Unichem Pharmaceuticals, 10 mg, bottle, 100 count, NDC 29300-0155-01

Updated

Updated May 22, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 7, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.